| Literature DB >> 35517662 |
Taofang Cheng1, Ji Ye2, Huiliang Li2, Hongyuan Dong2, Ning Xie3, Nan Mi2, Zhen Zhang2, Jingtao Zou4, Huizi Jin1, Weidong Zhang1,2.
Abstract
The compound Dan Zhi Tablet (DZT), a reputable traditional Chinese medicine prescription, is widely used for the treatment of ischemic stroke in clinic. However, its systematic chemical constituents have rarely been elucidated, which hampers its quality evaluation, the study of bioactive constituents and the mechanism of action interpretation. In this study, we developed a combination of multidimensional data acquisition and data processing strategy with the aim to globally and comprehensively identify the chemical constituents in DZT based on UPLC-TWIMS-QTOFMS. First, multidimensional acquisition modes (MSE, Fast DDA and HDMSE) were performed on UPLC-TWIMS-QTOFMS. Second, targeted characterizations of the known compounds and their analogues present in DZT were carried out on the basis of the corresponding commercial standards or Mass2Motifs. Third, untargeted identification of unknown compounds in DZT was performed by extracting shared Mass2Motifs from the raw fragmentation spectra. Finally, the coeluting isomers were characterized using a precursor and/or product ion mobility. Consequently, 202 compounds were detected from DZT: 29 of them were unambiguously identified by comparison with reference compounds, 29 unknown compounds were discovered in specific medicinal materials, and ten pairs of coeluting isomers, which could not be distinguished using conventional MSE or Fast-DDA, were resolved using HDMSE only. This strategy was successfully used for the rapid and global identification of complex compounds including known, unknown and coeluting isomeric compounds in DZT and provided helpful chemical information for further quality control, pharmacology and active mechanism research on DZT. This journal is © The Royal Society of Chemistry.Entities:
Year: 2019 PMID: 35517662 PMCID: PMC9062044 DOI: 10.1039/c8ra10100k
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1The flowchart for the analysis of complex chemical compounds from DZT.
Fig. 2The chemical structures of the 29 reference standards.
Fig. 3The representative base peak chromatograms (BPCs) of DZT both in positive (A) and negative ion modes (B).
Mass2Motifs of DZT in negative ion modea
| No. | Mass2Motifs | Characterization | |
|---|---|---|---|
| 1 | Frag | 191.0553 (C7H11O6), 173.0450 (C7H9O5) | Fragments related to quinic acid |
| 2 | Frag | 341.1082 (C12H21O11), 281.0878 (C10H17O9), 221.0660 (C8H13O7), 179.0552 (C6H11O6), 161.0445 (C6H9O5), 119.0342 (C4H7O4) | Fragments related to disaccharide |
| 3 | Frag | 545.1732 (C20H33O17), 383.1190 (C14H23O12), 221.0660 (C8H13O7), 179.0552 (C6H11O6), 161.0445 (C6H9O5), 119.0342 (C4H7O4) | Fragments related to polysaccharides |
| 4 | NL | 150.0528 (C5H10O5), 132.0423 (C5H8O4) | Pentose (xylose/arabinose/ribose) related loss |
| 5 | NL | 180.0634 (C6H12O6), 162.0528 (C6H10O5) | Hexose (glucose/galactose) related loss |
| 6 | NL | 164.0685 (C6H12O5), 146.0603 (C6H10O4) | Rhamnose-related loss |
| 7 | NL | 17.0267 (NH3) | Amino acid-related loss |
| 8 | NL | 42.0102 (C2H2O) | Acetyl group |
| 9 | NL | 100.0162 (C4H4O3) | Isopropyl group |
| 10 | NL | 15.0235 (CH3) | Methyl group |
| 11 | NL | 18.0106 (H2O) | Loss of water |
| 12 | NL | 27.9949 (CO) | Loss of C |
| 13 | NL | 43.9898 (CO2) | Carboxylic acid (CO2) group |
| 14 | Frag | 179.0340 (C9H7O4), 161.0231 (C9H5O3), 135.0446 (C8H7O2) | Fragments related to caffeic acid |
| 15 | NL | 180.0423 (C9H8O4) | Caffeic acid/salvianolic acid-related loss |
| 16 | NL | 162.0317 (C9H6O3) | Caffeoyl group/salvianolic acid-related loss |
| 17 | Frag | 197.0459 (C9H9O5), 179.0340 (C9H7O4), 135.0439 (C8H7O2) | Fragments related to danshensu |
| 18 | NL | 198.0528 (C9H10O5) | Danshensu/salvianolic acid-related loss |
| 19 | Frag | 519.0927 (C27H19O11), 339.0505 (C18H11O7), 321.0396 (C18H9O6), 295.0610 (C17H11O5), 197.0449 (C9H9O5), 179.0335 (C9H7O4), 161.0231 (C9H5O3) | Fragments related to salvianolic acids |
| 20 | Frag | 353.0875 (C16H17O9), 191.0553 (C7H11O6), 179.0340 (C9H7O4), 173.0445 (C7H9O5), 135.0439 (C8H7O2) | Fragments related to caffeoylquinic acids |
| 21 | Frag | 515.1190 (C25H23O12), 353.0875 (C16H17O9) | Fragments related to dicaffeoylquinic acids |
| 22a | Frag | 455.3525 (C30H47O3), 437.3420 (C30H45O2), 419.3314 (C30H43O) | Fragments related to astragaloside |
| 23 | NL | 180.0634 (C6H12O6), 162.0538 (C6H10O5), 146.0579 (C6H10O4), 132.0430 (C5H8O4) | Astragaloside-related loss |
| 24a | Frag | 184.0731 (C5H15NO4P), 124.9999 (C2H6O4P), 104.1068 (C5H14NO), 86.0961 (C5H12N) | Fragments related to lysoglycerophosphocholines |
| 25 | Frag | 242.0791 (C7H17NO6P), 224.0693 (C7H15NO5P), 168.0426 (C4H11NO4P), 78.9585 (PO3) | |
| 26 | NL | 60.0220 (CH3+CO2H) | Lysoglycerophosphocholine-related loss |
| 27 | Frag | 96.9595 (HSO4) | Sulphate group |
| 28 | Frag | 79.9562 (SO3) | Sulfate group |
| 29a | NL | 18.0106 (H2O), 27.9949 (CO), 28.0310 (C2H4), 42.0470 (C3H6), 56.0630 (C4H8) | Loss of phthalides |
| 30 | NL | 15.0235 (CH3), 18.0106 (H2O), 29.0391 (C2H5), 58.0780 (C4H10), 71.0860 (C5H11), 86.1096 (C6H14) | Loss of furan sulfonic acids |
| Frag | 79.9568 (SO3) | Fragment related to furan sulfonic acids | |
| 31 | NL | 157.1592 (C10H21O), 141.1643 (C10H21), 86.1096 (C6H14), 72.0939 (C5H12) | Loss of alkyl sulfuric acids |
| Frag | 96.9595 (HSO4), 79.9562 (SO3), 165.0217 (C5H9O4S) | Fragments related to alkyl sulfuric acids | |
a: Mass2Motifs in positive ion mode; Frag: fragment; NL: neutral loss.
Fig. 4The fragmentation patterns of salvianolic acid B (A), astragaloside III (B), 5-ethyl-2-hexylfuran-3-sulfonic acid (C) and tanshinone IIA (D) in DZT.
Fig. 5The proposed fragmentation pathways of lysoglycerophosphocholines in DZT. Fragment pattern in the positive ion mode (A), fragment pattern in the negative ion mode (B); fragmentation pathway of lysophosphatidylcholine O-16 : 0/0 : 0 (C) and fragmentation pathway of 1-stearoyl-lysophosphatidylcholine (D).
Fig. 6Characterization of isomers with precursor ions at m/z 717.1456 ppm in DZT: (A) extracted ion chromatography (EIC) of the precursor ions at m/z 717.1456 ± 5 ppm, including peaks 40 (blue trace), 48 (red trace), 51 (orange trace) and 53 (green trace); (B) mobility profiles of the m/z 717.1456 precursor ions of peaks 40, 48, 51 and 53; in addition, among them, peaks 40, 48 and 51 further dissociated into mobility peaks 40a/40b, 48a/48b and 51a/51b, respectively. (C) MS/MS spectrum of the precursor ions at m/z 717.1456 for mobility peaks 40a, 40b, 48a, 48b, 51a, 51b and 53.
Fig. 7Characterization of the CQA isomers with the precursor ions at m/z 353.0880 in DZT using precursor ion mobility: (A) extracted ion chromatography (EIC) of the m/z 353.0880 ± 5 ppm precursor ions including peaks 18 (blank trace), 20 (orange trace), 23 (blue trace) and 24 (green trace). (B) Overlaid mobility profiles of the m/z 353.0880 precursor ions of peaks 18, 20, 23 and 24; in addition, peaks 18, 23 and 24 among them further dissociated into valley-to-valley peaks, including mobility peaks 18a/18b, 23a/23b and 24a/24b, respectively. (C) MS/MS spectrum of the precursor ions at m/z 353.0880 for mobility peaks 18a, 18b, 20, 23a, 23b, 24a and 24b.
Fig. 8Characterization of the di-CQA isomers with the product ions at m/z 353.0880 ± 5 ppm derived from the precursor ions at m/z 515.1190 ± 5 ppm in DZT using product ion mobility: (A) extracted ion chromatography (EIC) of the m/z 353.0880 product ions including peaks 26 (blank), 33 (orange), 34 (azure), 36 (blue), 37b (green) and 42 (red). (B) Mobility profiles of the m/z 515.1190 precursor ions of peaks 33, 34, 36 and 42. (C) Mobility profiles of the m/z 353.0880 product ions of peaks 33a/33b, 34a/34b, 36a/36 and 42a/42b. (Peaks 33, 34, 36 and 42 further dissociated into valley-to-valley mobility peaks, including 33a/33b, 34a/34b, 36a/36 and 42a/42b, respectively.) (D) MS/MS spectrum of mobility peaks 33a, 33b, 34a, 34b, 36a, 36, 42a and 42b.